Mikael Dolsten - Director at ROCKET PHARMACEUTICALS, INC.

Issuer-level insider activity

Role: Director
Issuer ticker: RCKT, RCKTW on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Mikael Dolsten since 12 Aug 2025

Reported holdings for Mikael Dolsten in ROCKET PHARMACEUTICALS, INC.

Form 4 holding Director

ROCKET PHARMACEUTICALS, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 64,860
Estimated value: $345,740
Report date: 18 Jun 2026
Price: $15.04
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

ROCKET PHARMACEUTICALS, INC.

Security class: Common Stock
Shares / value: 67,082
Estimated value: $229,494
Report date: 18 Jun 2026
Price: $3.42
Ownership: Direct

Transaction history for Mikael Dolsten in ROCKET PHARMACEUTICALS, INC.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .